New contraindications and update of warning for the use of Protelos®

19 March 2012

Protelos® is no longer recommended for use in immobilised patients or patients with venous thromboembolism, and the product information will therefore be updated.

This follows from a review conducted by the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).

Please see the European Medicines Agency’s press release in the box to the right.